We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+31.27%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.91B
AUM Growth
+$590M
Cap. Flow
+$43.3M
Cap. Flow %
1.11%
Top 10 Hldgs %
41.55%
Holding
108
New
10
Increased
23
Reduced
13
Closed
15

Top Buys

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$49.2M
2
CRM icon
Salesforce
CRM
+$31.6M
3
RNAM
Avidity Biosciences
RNAM
+$30.3M
4
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$28.2M
5
FERG icon
Ferguson
FERG
+$26.4M

Top Sells

Rank Stock Value
1
ETNB
89bio
ETNB
+$60.4M
2
GEHC icon
GE HealthCare
GEHC
+$39.4M
3
DKS icon
Dick's Sporting Goods
DKS
+$28.8M
4
DDOG icon
Datadog
DDOG
+$24M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$16.7M

Sector Composition

Rank Sector Weight
1 Healthcare 51.02%
2 Technology 11.4%
3 Consumer Discretionary 5.04%
4 Financials 4.79%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
76
Stryker
SYK
$130B
$2.17M 0.06%
5,860
– –
DXCM icon
77
DexCom
DXCM
$32B
$2.13M 0.05%
31,680
– –
NTRA icon
78
Natera
NTRA
$46.4B
$1.63M 0.04%
10,100
– –
MCK icon
79
McKesson
MCK
$101B
$1.41M 0.04%
1,830
– –
IQV icon
80
IQVIA
IQV
$39.3B
$1.36M 0.03%
7,175
– –
HCA icon
81
HCA Healthcare
HCA
$89.5B
$1.36M 0.03%
3,190
– –
LKFT
82
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$1.29M 0.03%
37,111
– –
WAT icon
83
Waters Corp
WAT
$39.9B
$944K 0.02%
3,150
– –
AVTR icon
84
Avantor
AVTR
$9.19B
$897K 0.02%
71,850
– –
EW icon
85
Edwards Lifesciences
EW
$51.7B
$863K 0.02%
11,100
– –
IONS icon
86
Ionis Pharmaceuticals
IONS
$9.4B
$707K 0.02%
10,800
– –
RMD icon
87
ResMed
RMD
$30.7B
$654K 0.02%
2,390
– –
A icon
88
Agilent Technologies
A
$41.2B
$640K 0.02%
4,990
– –
VLTO icon
89
Veralto
VLTO
$24B
$584K 0.01%
5,475
– –
STE icon
90
Steris
STE
$23.1B
$379K 0.01%
1,530
– –
SRPT icon
91
Sarepta Therapeutics
SRPT
$1.77B
$345K 0.01%
17,888
– –
ZBH icon
92
Zimmer Biomet
ZBH
$18.4B
$321K 0.01%
3,260
– –
PACS icon
93
PACS Group
PACS
$7.67B
$275K 0.01%
20,000
– –
ALGN icon
94
Align Technology
ALGN
$12.3B
– –
-1,100
Closed -$208K
BAX icon
95
Baxter International
BAX
$14.2B
– –
-7,970
Closed -$241K
CRH icon
96
CRH
CRH
$66.8B
– –
-8,460
Closed -$777K
CZR icon
97
Caesars Entertainment
CZR
$6.14B
– –
-18,875
Closed -$536K
DDOG icon
98
Datadog
DDOG
$84B
– –
-178,832
Closed -$24M
GEHC icon
99
GE HealthCare
GEHC
$32.4B
– –
-532,280
Closed -$39.4M
IWM icon
100
PUT
iShares Russell 2000 ETF
IWM
$83B
– –
-702,500
Closed -$152M
1 2 3
4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Suvretta Capital Management held 108 positions worth $3.91B, up 18% from $3.32B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Suvretta Capital Management's Q3 2025 filing shows 10 new, 23 increased, 13 reduced and 15 closed positions. Its largest new stake was Keurig Dr Pepper: 1,570,000 shares worth $40.1M. The largest sale was 89bio, an estimated $60.4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Suvretta Capital Management's largest Q3 2025 buy was Keurig Dr Pepper: 1,570,000 shares worth $40.1M.
  • Suvretta Capital Management added most to Ferguson in Q3 2025, an estimated $26.4M increase.
  • Suvretta Capital Management's biggest Q3 2025 reduction was 89bio, cutting an estimated $60.4M.
  • Suvretta Capital Management fully exited GE HealthCare in Q3 2025, selling an estimated $39.4M.
  • Suvretta Capital Management's ten largest holdings make up 42% of its $3.91B portfolio in Q3 2025.
  • Suvretta Capital Management opened 10 new positions and closed 15 in Q3 2025.
  • Suvretta Capital Management's portfolio value rose 18% quarter-over-quarter to $3.91B.

Based on Suvretta Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.